Estradiol (E2) concentration shapes the chromatin binding landscape of estrogen receptor alpha
Journal of Biological Chemistry · 2025
DOI: 10.1016/j.jbc.2025.108499 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Amy L Han und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Estrogen Receptor alpha, Estradiol, Chromatin. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, NCI NIH HHS, Canadian Anesthesiologists' Society.
Abstract (Originalsprache)
How transcription factors (TFs) selectively occupy a minute subset of their binding sites from a sizeable pool of putative sites in large mammalian genomes remains an important unanswered question. In part, nucleosomes help by creating formidable barriers to TF binding. TF concentration itself plays a crucial role in the competition between TFs and nucleosomes. With nuclear receptors, the ligand adds another layer of complexity. Estrogen receptor alpha (ER) is a classic example where its main ligand estradiol (E2) can modulate ER binding on chromatin. Here, we show a shift in ER binding as a function of E2 concentration. As E2 concentration increases by two orders of magnitude, ER levels decrease, and ER binding localizes to promoter-distal sites with strong ER motifs. At low E2 levels, abundant levels of ER are present in the nucleus, and ER binding occurs mostly at sites without a canonical ER binding motif, in cooperation with other TFs like STAT1. We propose that E2's effect on ER activity plays a major role in defining genome-wide ER binding profiles. Thus, variations in E2 concentrations in ER-positive breast tumors could be a significant factor driving heterogeneity in tumor phenotype, treatment response, and potentially drug resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
- RNA Bioscience Initiative, Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
- Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
- RNA Bioscience Initiative, Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. Electronic address: Srinivas.Ramachandran@cuanschutz.edu.
- Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. Electronic address: Peter.Kabos@cuanschutz.edu.
Förderung
- NIDDK NIH HHS
- NCI NIH HHS
- Canadian Anesthesiologists' Society
- University of Colorado
- National Institutes of Health
- National Institutes of Health National Cancer Institute
Zitieren
APA
Han, A. L., Vinod Paul, K., Rao, S., Brechbuhl, H. M., Sartorius, C. A., Ramachandran, S., & Kabos, P. (2025). Estradiol (E2) concentration shapes the chromatin binding landscape of estrogen receptor alpha. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.108499
Vancouver
Han AL, Vinod Paul K, Rao S, Brechbuhl HM, Sartorius CA, Ramachandran S, et al. Estradiol (E2) concentration shapes the chromatin binding landscape of estrogen receptor alpha. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.108499
BibTeX
@article{Han2025,
author = {Han, Amy L and Vinod Paul, Kiran and Rao, Satyanarayan and Brechbuhl, Heather M and Sartorius, Carol A and Ramachandran, Srinivas and Kabos, Peter},
title = {Estradiol (E2) concentration shapes the chromatin binding landscape of estrogen receptor alpha},
journal = {Journal of Biological Chemistry},
year = {2025},
doi = {10.1016/j.jbc.2025.108499}
}
EUVIMED